Source-grounded facts extracted from MERIT MEDICAL SYSTEMS INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
MERIT MEDICAL SYSTEMS INC: Board adopted Fifth Amended and Restated Bylaws, making various clarifications and updates (effective 2026-05-14).
“On May 14, 2026, the Board approved and adopted the Fifth Amended and Restated Bylaws of the Company (the “Fifth A&R Bylaws”).”
MERIT MEDICAL SYSTEMS INC reported the quarter ended March 31, 2026 results: revenue $381.9 million, EPS GAAP EPS $0.68.
“ FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS FIRST QUARTER 2026 RESULTS AND UPDATES FULL-YEAR GUIDANCE Financial Highlights† ● Reported revenue of $381.9 million, up 7% ● Constant currency revenue* and constant currency revenue, organic* up 5% and up 3%, respectively o Constant currency revenue, organic* increased 4%, excluding revenue”
Fred P. Lampropoulos resigned as President at MERIT MEDICAL SYSTEMS INC.
“In connection with Mr. Wright’s appointment, Fred P. Lampropoulos resigned as President of Merit. Mr. Lampropoulos will continue to serve as Merit’s Chief Executive Officer.”
Joseph C. Wright was appointed as President at MERIT MEDICAL SYSTEMS INC.
“The Board of Directors of Merit Medical Systems, Inc. (“Merit”) appointed Joseph C. Wright as President of Merit, effective as of May 15, 2024.”
MERIT MEDICAL SYSTEMS INC reported first quarter ended March 31, 2024 results: revenue $323.5 million, EPS $0.48.
“mike.piccinino@westwicke.com FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS RESULTS FOR FIRST QUARTER ENDED MARCH 31, 2024 ● Q1 2024 reported revenue of $323.5 million, up 8.7% compared to Q1 2023 ● Q1 2024 constant currency revenue* up 9.3% compared to Q1 2023 ● Q1 2024 constant currency revenue, organic* up 7.0% compared to Q1 2023 ● Q1 2024”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.